Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 7.6. It has been cited 340 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.875
From this paper's citation signal
Citation Network Contribution
6.7
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
AstraZeneca
Grant: NCT01693562
AstraZeneca
Grant: NCT02087423
AstraZeneca
Grant: NCT02261220
Memorial Sloan Kettering Cancer Center
Grant: P30 CA008748
Damon Runyon Cancer Research Foundation
Grant: CI-98-18
NIH
Grant: T32-CA009207
NIH
Grant: K30-UL1TR00457
NCI NIH HHS
Grant: T32 CA009207
NCATS NIH HHS
Grant: UL1 TR000457
Parker Institute for Cancer Immunotherapy
FWCI
13.08
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals